. Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice. Alzheimers Dement. 2025 Mar;21(3):e70113. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.